Uncovering mechanisms underlying complement-mediated cancer immune evasion

被引：1
作者：
O'Connell, Patrick [1 ,2 ,3 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Mt Sinai Hosp, Dept Genet & Genom Sci, New York, NY USA
[3] Mt Sinai Hosp, Dept Pediat, New York, NY USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 02期
关键词：
D O I：
10.1016/j.ymthe.2024.01.012
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：277 / 278
页数：2
相关论文
共 9 条
[1]   An Immune Atlas of Clear Cell Renal Cell Carcinoma [J].
Chevrier, Stephane ;
Levine, Jacob Harrison ;
Zanotelli, Vito Riccardo Tomaso ;
Silina, Karina ;
Schulz, Daniel ;
Bacac, Marina ;
Ries, Carola Hermine ;
Ailles, Laurie ;
Jewett, Michael Alexander Spencer ;
Moch, Holger ;
van den Broek, Maries ;
Beisel, Christian ;
Stadler, Michael Beda ;
Gedye, Craig ;
Reis, Bernhard ;
Pe'er, Dana ;
Bodenmiller, Bernd .
CELL, 2017, 169 (04) :736-749
[2]   C5aR Expression in a Novel GFP Reporter Gene Knockin Mouse: Implications for the Mechanism of Action of C5aR Signaling in T Cell Immunity [J].
Dunkelberger, Jason ;
Zhou, Lin ;
Miwa, Takashi ;
Song, Wen-Chao .
JOURNAL OF IMMUNOLOGY, 2012, 188 (08) :4032-4042
[3]   Implications of macrophage polarization in autoimmunity [J].
Funes, Samanta C. ;
Rios, Mariana ;
Escobar-Vera, Jorge ;
Kalergis, Alexis M. .
IMMUNOLOGY, 2018, 154 (02) :186-195
[4]   Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer [J].
Gu, Jie ;
Ding, Jian-yong ;
Lu, Chun-lai ;
Lin, Zong-wu ;
Chu, Yi-wei ;
Zhao, Guang-yin ;
Guo, Jing ;
Ge, Di .
LUNG CANCER, 2013, 81 (02) :259-265
[5]   Complement-targeted therapy: development of C5- and C5a-targeted inhibition [J].
Horiuchi T. ;
Tsukamoto H. .
Inflammation and Regeneration, 36 (1)
[6]   Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+T cell activity [J].
Luan, Xiaojin ;
Lei, Ting ;
Fang, Jie ;
Liu, Xue ;
Fu, Huijia ;
Li, Yiran ;
Chu, Wei ;
Jiang, Peng ;
Tong, Chao ;
Qi, Hongbo ;
Fu, Yong .
MOLECULAR THERAPY, 2024, 32 (02) :469-489
[7]   Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy [J].
Medler, Terry R. ;
Murugan, Dhaarini ;
Horton, Wesley ;
Kumar, Sushil ;
Cotechini, Tiziana ;
Forsyth, Alexandra M. ;
Leyshock, Patrick ;
Leitenberger, Justin J. ;
Kulesz-Martin, Molly ;
Margolin, Adam A. ;
Werb, Zena ;
Coussens, Lisa M. .
CANCER CELL, 2018, 34 (04) :561-+
[8]   Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis [J].
Spera, Maria C. ;
Cesta, Maria C. ;
Zippoli, Mara ;
Varrassi, Giustino ;
Allegretti, Marcello .
PAIN AND THERAPY, 2022, 11 (04) :1113-1136
[9]   C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer [J].
Zhang, Chen ;
Cao, Kankan ;
Yang, Moran ;
Wang, Yiying ;
He, Mengdi ;
Lu, Jiaqi ;
Huang, Yan ;
Zhang, Guodong ;
Liu, Haiou .
ONCOIMMUNOLOGY, 2023, 12 (01)
1